| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 48.35B | 43.99B | 42.61B | 41.37B | 28.84B |
| Gross Profit | 8.46B | 8.40B | 8.73B | 10.26B | 8.86B |
| EBITDA | 3.67B | 4.61B | 3.24B | 5.57B | 7.00B |
| Net Income | 601.50M | 1.81B | 292.33M | 1.94B | 4.03B |
Balance Sheet | |||||
| Total Assets | 71.87B | 71.25B | 69.24B | 70.08B | 66.81B |
| Cash, Cash Equivalents and Short-Term Investments | 17.64B | 18.24B | 13.75B | 12.08B | 15.27B |
| Total Debt | 2.79B | 2.80B | 3.09B | 4.52B | 6.33B |
| Total Liabilities | 33.50B | 32.18B | 30.46B | 30.17B | 28.44B |
| Stockholders Equity | 35.97B | 36.62B | 36.16B | 37.46B | 36.19B |
Cash Flow | |||||
| Free Cash Flow | 1.89B | 3.26B | 3.67B | 2.43B | 2.81B |
| Operating Cash Flow | 2.51B | 3.87B | 4.61B | 3.32B | 3.41B |
| Investing Cash Flow | -5.06B | 1.69B | -354.10M | 755.46M | -25.09B |
| Financing Cash Flow | -983.13M | -2.82B | -2.79B | -4.41B | 18.30B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | HK$17.13B | 10.46 | 15.06% | 4.43% | 4.91% | 4.61% | |
71 Outperform | HK$14.44B | 12.63 | 11.18% | 2.78% | 6.95% | 28.21% | |
70 Outperform | HK$12.84B | 5.67 | 23.68% | 3.82% | 6.30% | -9.60% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
61 Neutral | HK$20.45B | -49.97 | 4.63% | 1.77% | 2.94% | -39.39% | |
58 Neutral | HK$15.68B | 5.47 | 74.40% | ― | 6.46% | -3.32% | |
57 Neutral | HK$20.16B | -11.05 | 1.68% | 4.94% | 9.98% | -68.38% |